India's Serum Institute of India (SII) has announced that it will manufacture an experimental tuberculosis (TB) vaccine under ...

A new study conducted by the World Health Organization (WHO) suggests that in addition to providing significant improvements in public health, investment in the diagnosis and prevention of ...

Despite efforts to eliminate the disease, 13 million Americans are living with latent tuberculosis infection, according to the most recent statistics from the National Health and Nutrition Examination ...

Tuberculosis (TB) remains the world's leading cause of death from a single infectious agent. A new study recently published in The Lancet Global Health and supported by the World Health Organization ...

Dolutegravir-based ART with isoniazid was safe and effective for tuberculosis prevention in ART-naïve HIV patients, leading to rapid viral suppression. The study reported minimal adverse events, with ...

IntelliGenome, Inc., a biotechnology company developing CRISPR-based molecular diagnostics, today announced the appointment of ILEX South Africa (Pty) Ltd. as its exclusive distributor for CRISPR-TB® ...

Taking a common antibiotic could more than half the risk of children becoming sick with multidrug resistant tuberculosis (MDR-TB), according to findings presented this week at a conference on lung ...

Tuberculosis (TB) can transmit via the air, and the risk of infection depends on several factors. These can include the duration of exposure, proximity to a person with the infection, and immune ...

The number of U.S. tuberculosis cases in 2023 was the highest in a decade, the Centers for Disease Control and Prevention has announced. The CDC said on its website Thursday that "overall, cases ...

A 3-month, 12-dose regimen of rifapentine and isoniazid (INH) was less toxic, had better compliance, and showed similar efficacy as 6 months of INH alone in preventing tuberculosis (TB) in people with ...

San Diego County’s Tuberculosis Prevention and Care Program Friday announced a potential exposure to multidrug-resistant ...